Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
Jesús F. San Miguel, Rudolf Schlag(Orthopädische Praxis), Nuriet K. Khuageva(Botkin Hospital), Meletios Α. Dimopoulos(National and Kapodistrian University of Athens), Ofer Shpilberg(Rabin Medical Center), Martin Kropff(University of Münster), Ivan Špıčka(General University Hospital in Prague), Maria Teresa Petrucci(Sapienza University of Rome), Antonio Palumbo(University of Turin), Olga Samoilova(Nizhny Novgorod Regional Clinical Hospital named after Semashko), Anna Dmoszyńska(Medical University of Lublin), Abdulkadyrov Km(Russian Research Institute of Hematology and Transfusiology), Rik Schots(Orthopädische Praxis), Bin Jiang(Peking University), María-Victoria Mateos, Kenneth C. Anderson(Dana-Farber Cancer Institute), Dixie Esseltine(Millennium Engineering and Integration (United States)), Kevin Liu(Johnson & Johnson (United States)), Andrew Cakana, Helgi van de Velde, Paul G. Richardson(Dana-Farber Cancer Institute)
Cited by 1,904Open Access
Abstract
12 páginas, 2 figuras, 3 tablas.-- Presented in part at the annual meeting of the American Society \nof Hematology, Atlanta, December 10, 2007.-- et al.
Related Papers
No related papers found
Powered by citation graph analysis